<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39339717</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2072-6643</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>18</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>15</Day></PubDate></JournalIssue><Title>Nutrients</Title><ISOAbbreviation>Nutrients</ISOAbbreviation></Journal><ArticleTitle>Factors Affecting Adherence to a Low Phenylalanine Diet in Patients with Phenylketonuria: A Systematic Review.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">3119</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/nu16183119</ELocationID><Abstract><AbstractText>Phenylketonuria (PKU) is an inherited metabolic disorder that requires lifelong adherence to a low-phenylalanine (Phe) diet to prevent severe neurological complications. However, maintaining dietary adherence can be challenging for patients and their families. This systematic review aimed to comprehensively evaluate the factors affecting adherence to a low-Phe diet in patients with PKU. A systematic search of multiple databases was conducted, and 49 studies were included in the final analysis. The quality of evidence was assessed using the Joanna Briggs Institute levels of evidence and the Quality Assessment with Diverse Studies tool. The review identified four main categories of factors influencing dietary adherence: family-related factors (social, psychological, behavioral, and educational), patient-specific factors (psychological, behavioral, educational, and demographic), environmental factors (healthcare professional support, educational and camp-based interventions, and the COVID-19 pandemic), and therapy-related factors (protein substitute formulation, clinic visits, blood tests, and telemedicine). The findings highlight the complex interplay between elements contributing to dietary adherence in PKU patients and underscore the importance of a multifaceted approach to support patients and their families. Future research should prioritize high-quality longitudinal and experimental studies to provide stronger evidence for the PKU community.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yagudina</LastName><ForeName>Roza</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Organization of Medical Provision and Pharmacoeconomics, Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str. 8/2, 119991 Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kulikov</LastName><ForeName>Andrey</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7025-1185</Identifier><AffiliationInfo><Affiliation>Department of Organization of Medical Provision and Pharmacoeconomics, Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str. 8/2, 119991 Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serpik</LastName><ForeName>Vyacheslav</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Organization of Medical Provision and Pharmacoeconomics, Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str. 8/2, 119991 Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Protsenko</LastName><ForeName>Marina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Organization of Medical Provision and Pharmacoeconomics, Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str. 8/2, 119991 Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kopeyka</LastName><ForeName>Kirill</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Organization of Medical Provision and Pharmacoeconomics, Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str. 8/2, 119991 Moscow, Russia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Nutrients</MedlineTA><NlmUniqueID>101521595</NlmUniqueID><ISSNLinking>2072-6643</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>47E5O17Y3R</RegistryNumber><NameOfSubstance UI="D010649">Phenylalanine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010349" MajorTopicYN="Y">Patient Compliance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010649" MajorTopicYN="Y">Phenylalanine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010661" MajorTopicYN="Y">Phenylketonurias</DescriptorName><QualifierName UI="Q000178" MajorTopicYN="N">diet therapy</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">PKU</Keyword><Keyword MajorTopicYN="N">barriers</Keyword><Keyword MajorTopicYN="N">compliance</Keyword><Keyword MajorTopicYN="N">dietary adherence</Keyword><Keyword MajorTopicYN="N">facilitators</Keyword><Keyword MajorTopicYN="N">low-Phe diet</Keyword><Keyword MajorTopicYN="N">phenylketonuria</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>29</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39339717</ArticleId><ArticleId IdType="pmc">PMC11435312</ArticleId><ArticleId IdType="doi">10.3390/nu16183119</ArticleId><ArticleId IdType="pii">nu16183119</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Blau N., van Spronsen F.J., Levy H.L. Phenylketonuria. Lancet. 2010;376:1417–1427. doi: 10.1016/S0140-6736(10)60961-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)60961-0</ArticleId><ArticleId IdType="pubmed">20971365</ArticleId></ArticleIdList></Reference><Reference><Citation>Vockley J., Andersson H.C., Antshel K.M., Braverman N.E., Burton B.K., Frazier D.M., Mitchell J., Smith W.E., Thompson B.H., Berry S.A., et al. Phenylalanine hydroxylase deficiency: Diagnosis and management guideline. Genet. Med. 2014;16:188–200. doi: 10.1038/gim.2013.157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gim.2013.157</ArticleId><ArticleId IdType="pubmed">24385074</ArticleId></ArticleIdList></Reference><Reference><Citation>Giovannini M., Verduci E., Salvatici E., Paci S., Riva E. Phenylketonuria: Nutritional advances and challenges. Nutr. Metab. 2012;9:7. doi: 10.1186/1743-7075-9-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-7075-9-7</ArticleId><ArticleId IdType="pmc">PMC3395819</ArticleId><ArticleId IdType="pubmed">22305125</ArticleId></ArticleIdList></Reference><Reference><Citation>MacDonald A., Gokmen-Ozel H., van Rijn M., Burgard P. The reality of dietary compliance in the management of phenylketonuria. J. Inherit. Metab. Dis. 2010;33:665–670. doi: 10.1007/s10545-010-9073-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10545-010-9073-y</ArticleId><ArticleId IdType="pubmed">20373144</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilginsoy C., Waitzman N., Leonard C.O., Ernst S.L. Living with phenylketonuria: Perspectives of patients and their families. J. Inherit. Metab. Dis. 2005;28:639–649. doi: 10.1007/s10545-005-4478-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10545-005-4478-8</ArticleId><ArticleId IdType="pubmed">16151894</ArticleId></ArticleIdList></Reference><Reference><Citation>Ford S., O’Driscoll M., MacDonald A. Living with Phenylketonuria: Lessons from the PKU community. Mol. Genet. Metab. Rep. 2018;17:57–63. doi: 10.1016/j.ymgmr.2018.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymgmr.2018.10.002</ArticleId><ArticleId IdType="pmc">PMC6198120</ArticleId><ArticleId IdType="pubmed">30364670</ArticleId></ArticleIdList></Reference><Reference><Citation>Gokmen-Ozel H., Ferguson C., Evans S., Daly A., MacDonald A. Does a lower carbohydrate protein substitute impact on blood phenylalanine control, growth and appetite in children with PKU? Mol. Genet. Metab. 2011;104:S64–S67. doi: 10.1016/j.ymgme.2011.09.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymgme.2011.09.014</ArticleId><ArticleId IdType="pubmed">21978770</ArticleId></ArticleIdList></Reference><Reference><Citation>Uman L.S. Systematic Reviews and Meta-Analyses. J. Can. Acad. Child Adolesc. Psychiatry. 2011;20:57–59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3024725</ArticleId><ArticleId IdType="pubmed">21286370</ArticleId></ArticleIdList></Reference><Reference><Citation>Petticrew M., Roberts H. Systematic Reviews in the Social Sciences: A Practical Guide. 1st ed. Blackwell Pub; Malden, MA, USA: Oxford, UK: 2006. 336p</Citation></Reference><Reference><Citation>Medford E., Hare D.J., Wittkowski A. Demographic and Psychosocial Influences on Treatment Adherence for Children and Adolescents with PKU: A Systematic Review. JIMD Rep. 2018;39:107–116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5953888</ArticleId><ArticleId IdType="pubmed">28840576</ArticleId></ArticleIdList></Reference><Reference><Citation>Page M.J., McKenzie J.E., Bossuyt P.M., Boutron I., Hoffmann T.C., Mulrow C.D., Shamseer L., Tetzlaff J.M., Akl E.A., Brennan S.E., et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute of Health and Care Research (NIHR)  Factors Affecting Adherence to a Low Phenylalanine Diet in Children with Phenylketonuria: A Systematic Review [Internet]. PROSPERO International Prospective Register of Systematic Reviews.  [(accessed on 23 March 2024)].  Available online:  https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=412538.</Citation></Reference><Reference><Citation>Amir-Behghadami M., Janati A. Population, Intervention, Comparison, Outcomes and Study (PICOS) design as a framework to formulate eligibility criteria in systematic reviews. Emerg. Med. J. 2020;37:387. doi: 10.1136/emermed-2020-209567.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/emermed-2020-209567</ArticleId><ArticleId IdType="pubmed">32253195</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolters Kluwer Health  JBI Levels of Evidence. Levels of Evidence—Effectiveness [Internet]. JBI EBP Database.  [(accessed on 23 March 2024)].  Available online:  https://ospguides.ovid.com/OSPguides/jbidb.htm.</Citation></Reference><Reference><Citation>Harrison R., Jones B., Gardner P., Lawton R. Quality assessment with diverse studies (QuADS): An appraisal tool for methodological and reporting quality in systematic reviews of mixed- or multi-method studies. BMC Health Serv. Res. 2021;21:144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7885606</ArticleId><ArticleId IdType="pubmed">33588842</ArticleId></ArticleIdList></Reference><Reference><Citation>Fehrenbach A.M., Peterson L. Parental problem-solving skills, stress, and dietary compliance in phenylketonuria. J. Consult. Clin. Psychol. 1989;57:237–241. doi: 10.1037/0022-006X.57.2.237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/0022-006X.57.2.237</ArticleId><ArticleId IdType="pubmed">2708611</ArticleId></ArticleIdList></Reference><Reference><Citation>Shulman S., Fisch R.O., Zempel C.E., Gadish O., Chang P.N. Children with phenylketonuria: The interface of family and child functioning. J. Dev. Behav. Pediatr. 1991;12:315–321. doi: 10.1097/00004703-199110000-00006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00004703-199110000-00006</ArticleId><ArticleId IdType="pubmed">1939688</ArticleId></ArticleIdList></Reference><Reference><Citation>Gleason L.A., Michals K., Matalon R., Langenberg P., Kamath S. A treatment program for adolescents with phenylketonuria. Clin. Pediatr. 1992;31:331–335. doi: 10.1177/000992289203100603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/000992289203100603</ArticleId><ArticleId IdType="pubmed">1628465</ArticleId></ArticleIdList></Reference><Reference><Citation>McMurry M.P., Chan G.M., Leonard C.O., Ernst S.L. Bone mineral status in children with phenylketonuria—Relationship to nutritional intake and phenylalanine control. Am. J. Clin. Nutr. 1992;55:997–1004. doi: 10.1093/ajcn/55.5.997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/55.5.997</ArticleId><ArticleId IdType="pubmed">1570811</ArticleId></ArticleIdList></Reference><Reference><Citation>Waisbren S.E., Hamilton B.D., St James P.J., Shiloh S., Levy H.L. Psychosocial factors in maternal phenylketonuria: Women’s adherence to medical recommendations. Am. J. Public. Health. 1995;85:1636–1641. doi: 10.2105/AJPH.85.12.1636.</Citation><ArticleIdList><ArticleId IdType="doi">10.2105/AJPH.85.12.1636</ArticleId><ArticleId IdType="pmc">PMC1615717</ArticleId><ArticleId IdType="pubmed">7503337</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulz B., Bremer H.J. Nutrient intake and food consumption of adolescents and young adults with phenylketonuria. Acta Paediatr. 1995;84:743–748. doi: 10.1111/j.1651-2227.1995.tb13748.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1651-2227.1995.tb13748.x</ArticleId><ArticleId IdType="pubmed">7549290</ArticleId></ArticleIdList></Reference><Reference><Citation>Waisbren S.E., Rokni H., Bailey I., Rohr F., Brown T., Warner-Rogers J. Social factors and the meaning of food in adherence to medical diets: Results of a maternal phenylketonuria summer camp. J. Inherit. Metab. Dis. 1997;20:21–27. doi: 10.1023/A:1005349204797.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1005349204797</ArticleId><ArticleId IdType="pubmed">9061563</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Qadreh A., Schulpis K.H., Athanasopoulou H., Mengreli C., Skarpalezou A., Voskaki I. Bone mineral status in children with phenylketonuria under treatment. Acta Paediatr. 1998;87:1162–1166. doi: 10.1111/j.1651-2227.1998.tb00924.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1651-2227.1998.tb00924.x</ArticleId><ArticleId IdType="pubmed">9846918</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh R.H., Kable J.A., Guerrero N.V., Sullivan K.M., Elsas L.J. Impact of a camp experience on phenylalanine levels, knowledge, attitudes, and health beliefs relevant to nutrition management of phenylketonuria in adolescent girls. J. Am. Diet. Assoc. 2000;100:797–803. doi: 10.1016/S0002-8223(00)00232-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-8223(00)00232-7</ArticleId><ArticleId IdType="pubmed">10916518</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown A.S., Fernhoff P.M., Waisbren S.E., Frazier D.M., Singh R., Rohr F., Morris J.M., Kenneson A., MacDonald P., Gwinn M., et al. Barriers to successful dietary control among pregnant women with phenylketonuria. Genet. Med. 2002;4:84–89. doi: 10.1097/00125817-200203000-00006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00125817-200203000-00006</ArticleId><ArticleId IdType="pubmed">11882785</ArticleId></ArticleIdList></Reference><Reference><Citation>MacDonald A., Ferguson C., Rylance G., Morris A., Asplin D., Hall S., Booth I. Are tablets a practical source of protein substitute in phenylketonuria? Arch. Dis. Child. 2003;88:327–329. doi: 10.1136/adc.88.4.327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/adc.88.4.327</ArticleId><ArticleId IdType="pmc">PMC1719524</ArticleId><ArticleId IdType="pubmed">12651759</ArticleId></ArticleIdList></Reference><Reference><Citation>Bekhof J., van Spronsen F.J., Crone M.R., van Rijn M., Oudshoorn C.G.M., Verkerk P.H. Influence of knowledge of the disease on metabolic control in phenylketonuria. Eur. J. Pediatr. 2003;162:440–442. doi: 10.1007/s00431-003-1197-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-003-1197-8</ArticleId><ArticleId IdType="pubmed">12684903</ArticleId></ArticleIdList></Reference><Reference><Citation>Camfield C.S., Joseph M., Hurley T., Campbell K., Sanderson S., Camfield P.R. Optimal management of phenylketonuria: A centralized expert team is more successful than a decentralized model of care. J. Pediatr. 2004;145:53–57. doi: 10.1016/j.jpeds.2004.04.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2004.04.029</ArticleId><ArticleId IdType="pubmed">15238907</ArticleId></ArticleIdList></Reference><Reference><Citation>Antshel K.M., Brewster S., Waisbren S.E. Child and parent attributions in chronic pediatric conditions: Phenylketonuria (PKU) as an exemplar. J. Child. Psychol. Psychiatry. 2004;45:622–630. doi: 10.1111/j.1469-7610.2004.00251.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-7610.2004.00251.x</ArticleId><ArticleId IdType="pubmed">15055380</ArticleId></ArticleIdList></Reference><Reference><Citation>Crone M.R., van Spronsen F.J., Oudshoorn K., Bekhof J., van Rijn G., Verkerk P.H. Behavioural factors related to metabolic control in patients with phenylketonuria. J. Inherit. Metab. Dis. 2005;28:627–637. doi: 10.1007/s10545-005-0014-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10545-005-0014-0</ArticleId><ArticleId IdType="pubmed">16151893</ArticleId></ArticleIdList></Reference><Reference><Citation>Ievers-Landis C.E., Hoff A.L., Brez C., Cancilliere M.K., McConnell J., Kerr D. Situational analysis of dietary challenges of the treatment regimen for children and adolescents with phenylketonuria and their primary caregivers. J. Dev. Behav. Pediatr. 2005;26:186–193. doi: 10.1097/00004703-200506000-00004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00004703-200506000-00004</ArticleId><ArticleId IdType="pubmed">15956867</ArticleId></ArticleIdList></Reference><Reference><Citation>MacDonald A., Lilburn M., Davies P., Evans S., Daly A., Hall S.K., Hendriksz C., Chakrapani A., Lee P. “Ready to drink” protein substitute is easier is for people with phenylketonuria. J. Inherit. Metab. Dis. 2006;29:526–531. doi: 10.1007/s10545-006-0234-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10545-006-0234-y</ArticleId><ArticleId IdType="pubmed">16736099</ArticleId></ArticleIdList></Reference><Reference><Citation>VanZutphen K.H., Packman W., Sporri L., Needham M.C., Morgan C., Weisiger K., Packman S. Executive functioning in children and adolescents with phenylketonuria. Clin. Genet. 2007;72:13–18. doi: 10.1111/j.1399-0004.2007.00816.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-0004.2007.00816.x</ArticleId><ArticleId IdType="pubmed">17594394</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsson G.M., Montgomery S.M., Alm J. Family conditions and dietary control in phenylketonuria. J. Inherit. Metab. Dis. 2007;30:708–715. doi: 10.1007/s10545-007-0493-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10545-007-0493-2</ArticleId><ArticleId IdType="pubmed">17570079</ArticleId></ArticleIdList></Reference><Reference><Citation>Durham-Shearer S.J., Judd P.A., Whelan K., Thomas J.E. Knowledge, compliance and serum phenylalanine concentrations in adolescents and adults with phenylketonuria and the effect of a patient-focused educational resource. J. Hum. Nutr. Diet. 2008;21:474–485. doi: 10.1111/j.1365-277X.2008.00879.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-277X.2008.00879.x</ArticleId><ArticleId IdType="pubmed">18833588</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozel H.G., Kucukkasap T., Koksal G., Sivri H.S.K., Dursun A., Tokatli A., Coskun T. Does maternal knowledge impact blood phenylalanine concentration in Turkish children with phenylketonuria? J. Inherit. Metab. Dis. 2008;31((Suppl. 2)):S213–S217. doi: 10.1007/s10545-008-0775-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10545-008-0775-3</ArticleId><ArticleId IdType="pubmed">18581253</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharman R., Sullivan K., Young R., McGill J. Biochemical markers associated with executive function in adolescents with early and continuously treated phenylketonuria. Clin. Genet. 2009;75:169–174. doi: 10.1111/j.1399-0004.2008.01101.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-0004.2008.01101.x</ArticleId><ArticleId IdType="pubmed">19215250</ArticleId></ArticleIdList></Reference><Reference><Citation>Peipert J., Rohr F., Phornphutkul C., Waisbren S. Changes in Metabolic Control of Phenylketonuria in Children Attending a Summer Camp: Pre- and Postassessment of a Nutritional Intervention. ICAN Infant Child Adolesc. Nutr. 2010;2:117–119. doi: 10.1177/1941406410364544.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1941406410364544</ArticleId></ArticleIdList></Reference><Reference><Citation>Viau K.S., Wengreen H.J., Ernst S.L., Cantor N.L., Furtado L.V., Longo N. Correlation of age-specific phenylalanine levels with intellectual outcome in patients with phenylketonuria. J. Inherit. Metab. Dis. 2011;34:963–971. doi: 10.1007/s10545-011-9329-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10545-011-9329-1</ArticleId><ArticleId IdType="pubmed">21556836</ArticleId></ArticleIdList></Reference><Reference><Citation>Cotugno G., Nicolò R., Cappelletti S., Goffredo B.M., Dionisi Vici C., Di Ciommo V. Adherence to diet and quality of life in patients with phenylketonuria. Acta Paediatr. 2011;100:1144–1149. doi: 10.1111/j.1651-2227.2011.02227.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1651-2227.2011.02227.x</ArticleId><ArticleId IdType="pubmed">21342250</ArticleId></ArticleIdList></Reference><Reference><Citation>Alaei M., Asadzadeh-Totonchi G., Gachkar L., Farivar S. Family Social Status and Dietary Adherence of Patients with Phenylketonuria. Iran. J. Pediatr. 2011;21:379–384.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3446194</ArticleId><ArticleId IdType="pubmed">23056817</ArticleId></ArticleIdList></Reference><Reference><Citation>Macdonald A., Nanuwa K., Parkes L., Nathan M., Chauhan D. Retrospective, observational data collection of the treatment of phenylketonuria in the UK, and associated clinical and health outcomes. Curr. Med. Res. Opin. 2011;27:1211–1222. doi: 10.1185/03007995.2011.576237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1185/03007995.2011.576237</ArticleId><ArticleId IdType="pubmed">21504301</ArticleId></ArticleIdList></Reference><Reference><Citation>Freehauf C., Van Hove J.L.K., Gao D., Bernstein L., Thomas J.A. Impact of geographic access to care on compliance and metabolic control in phenylketonuria. Mol. Genet. Metab. 2013;108:13–17. doi: 10.1016/j.ymgme.2012.09.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymgme.2012.09.026</ArticleId><ArticleId IdType="pubmed">23177662</ArticleId></ArticleIdList></Reference><Reference><Citation>Vieira T.A., Nalin T., Krug B.C., Bittar C.M., Netto C.B.O., Schwartz I.V.D. Adherence to Treatment of Phenylketonuria: A Study in Southern Brazilian Patients. J. Inborn Errors Metab. Screen. 2015;3:2326409815579861. doi: 10.1177/2326409815579861.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2326409815579861</ArticleId></ArticleIdList></Reference><Reference><Citation>Medford E., Hare D.J., Carpenter K., Rust S., Jones S., Wittkowski A. Treatment Adherence and Psychological Wellbeing in Maternal Carers of Children with Phenylketonuria (PKU) JIMD Rep. 2017;37:107–114.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5740045</ArticleId><ArticleId IdType="pubmed">28382600</ArticleId></ArticleIdList></Reference><Reference><Citation>Jurecki E.R., Cederbaum S., Kopesky J., Perry K., Rohr F., Sanchez-Valle A., Viau K.S., Sheinin M.Y., Cohen-Pfeffer J.L. Adherence to clinic recommendations among patients with phenylketonuria in the United States. Mol. Genet. Metab. 2017;120:190–197. doi: 10.1016/j.ymgme.2017.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymgme.2017.01.001</ArticleId><ArticleId IdType="pubmed">28162992</ArticleId></ArticleIdList></Reference><Reference><Citation>Riva M.A., Madotto F., Turato M., Salvatici E., Indovina S., Giovannini M., Riva E., Cesana G. Work activity and phenylalanine levels in a population of young adults with classic PKU. Med. Lav. 2017;108:118–122.</Citation><ArticleIdList><ArticleId IdType="pubmed">28446738</ArticleId></ArticleIdList></Reference><Reference><Citation>García M.I., Araya G., Coo S., Waisbren S.E., de la Parra A. Treatment adherence during childhood in individuals with phenylketonuria: Early signs of treatment discontinuation. Mol. Genet. Metab. Rep. 2017;11:54–58. doi: 10.1016/j.ymgmr.2017.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymgmr.2017.04.006</ArticleId><ArticleId IdType="pmc">PMC5412103</ArticleId><ArticleId IdType="pubmed">28491816</ArticleId></ArticleIdList></Reference><Reference><Citation>Mlčoch T., Puda R., Ješina P., Lhotáková M., Štěrbová Š., Doležal T. Dietary patterns, cost and compliance with low-protein diet of phenylketonuria and other inherited metabolic diseases. Eur. J. Clin. Nutr. 2018;72:87–92. doi: 10.1038/ejcn.2017.102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ejcn.2017.102</ArticleId><ArticleId IdType="pubmed">28656971</ArticleId></ArticleIdList></Reference><Reference><Citation>Iakovou K., Schulpis K. The significant role of educational status in PKU patients: The beneficial effect of psychological support in depression. Int. J. Adolesc. Med. Health. 2019;33:20180233. doi: 10.1515/ijamh-2018-0233.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/ijamh-2018-0233</ArticleId><ArticleId IdType="pubmed">30888965</ArticleId></ArticleIdList></Reference><Reference><Citation>Walkowiak D., Bukowska-Posadzy A., Kałużny Ł., Ołtarzewski M., Staszewski R., Musielak M., Walkowiak J. Therapy compliance in children with phenylketonuria younger than 5 years: A cohort study. Adv. Clin. Exp. Med. 2019;28:1385–1391. doi: 10.17219/acem/104536.</Citation><ArticleIdList><ArticleId IdType="doi">10.17219/acem/104536</ArticleId><ArticleId IdType="pubmed">31469949</ArticleId></ArticleIdList></Reference><Reference><Citation>Burlina A.P., Cazzorla C., Massa P., Loro C., Gueraldi D., Burlina A.B. The Impact of a Slow-Release Large Neutral Amino Acids Supplement on Treatment Adherence in Adult Patients with Phenylketonuria. Nutrients. 2020;12:2078. doi: 10.3390/nu12072078.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12072078</ArticleId><ArticleId IdType="pmc">PMC7400920</ArticleId><ArticleId IdType="pubmed">32674279</ArticleId></ArticleIdList></Reference><Reference><Citation>Teruya K.I., Remor E., Schwartz I.V.D. Development of an inventory to assess perceived barriers related to PKU treatment. J. Patient Rep. Outcomes. 2020;4:29. doi: 10.1186/s41687-020-00194-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41687-020-00194-w</ArticleId><ArticleId IdType="pmc">PMC7195505</ArticleId><ArticleId IdType="pubmed">32358708</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenneson A., Singh R.H. Natural history of children and adults with phenylketonuria in the NBS-PKU Connect registry. Mol. Genet. Metab. 2021;134:243–249. doi: 10.1016/j.ymgme.2021.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymgme.2021.10.001</ArticleId><ArticleId IdType="pubmed">34654619</ArticleId></ArticleIdList></Reference><Reference><Citation>Teruya K.I., Remor E., Schwartz I.V.D. Factors that increase risk for poor adherence to phenylketonuria treatment in Brazilian patients. Am. J. Med. Genet. A. 2021;185:1991–2002. doi: 10.1002/ajmg.a.62195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajmg.a.62195</ArticleId><ArticleId IdType="pubmed">33765361</ArticleId></ArticleIdList></Reference><Reference><Citation>Borghi L., Salvatici E., Banderali G., Riva E., Giovannini M., Vegni E. Psychological wellbeing in parents of children with phenylketonuria and association with treatment adherence. Minerva Pediatr. 2021;73:330–339. doi: 10.23736/S2724-5276.18.05126-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S2724-5276.18.05126-5</ArticleId><ArticleId IdType="pubmed">29651832</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamani R., Karimi-Shahanjarini A., Tapak L., Moeini B. Improving phenylalanine and micronutrients status of children with phenylketonuria: A pilot randomized study. Orphanet J. Rare Dis. 2021;16:475. doi: 10.1186/s13023-021-02094-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13023-021-02094-8</ArticleId><ArticleId IdType="pmc">PMC8588614</ArticleId><ArticleId IdType="pubmed">34772434</ArticleId></ArticleIdList></Reference><Reference><Citation>Rovelli V., Zuvadelli J., Ercoli V., Montanari C., Paci S., Dionigi A.R., Scopari A., Salvatici E., Cefalo G., Banderali G. PKU and COVID19: How the pandemic changed metabolic control. Mol. Genet. Metab. Rep. 2021;27:100759. doi: 10.1016/j.ymgmr.2021.100759.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymgmr.2021.100759</ArticleId><ArticleId IdType="pmc">PMC8063433</ArticleId><ArticleId IdType="pubmed">33907667</ArticleId></ArticleIdList></Reference><Reference><Citation>Walkowiak D., Mikołuć B., Mozrzymas R., Kałużny Ł., Didycz B., Korycińska-Chaaban D., Patalan M., Jagłowska J., Chrobot A., Starostecka E., et al. The Impact of the COVID-19 Pandemic on the Perception of Health and Treatment-Related Issues among Patients with Phenylketonuria in Poland-The Results of a National Online Survey. Int. J. Environ. Res. Public Health. 2021;18:6399. doi: 10.3390/ijerph18126399.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18126399</ArticleId><ArticleId IdType="pmc">PMC8296241</ArticleId><ArticleId IdType="pubmed">34199184</ArticleId></ArticleIdList></Reference><Reference><Citation>Peres M., Almeida M.F., Pinto É.J., Carmona C., Rocha S., Guimas A., Ribeiro R., Martins E., Bandeira A., MacDonald A., et al. Implementing a Transition Program from Paediatric to Adult Services in Phenylketonuria: Results after Two Years of Follow-Up with an Adult Team. Nutrients. 2021;13:799. doi: 10.3390/nu13030799.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13030799</ArticleId><ArticleId IdType="pmc">PMC8001271</ArticleId><ArticleId IdType="pubmed">33671057</ArticleId></ArticleIdList></Reference><Reference><Citation>Zubarioglu T., Hopurcuoglu D., Uygur E., Ahmadzada S., Oge-Enver E., Isat E., Cansever M.S., Kiykim E., Aktuglu-Zeybek C. The Impact of Telemedicine for Monitoring and Treatment of Phenylketonuria Patients on Metabolic Outcome During Coronavirus Disease-19 Outbreak. Telemed. J. E Health. 2022;28:258–265. doi: 10.1089/tmj.2020.0569.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/tmj.2020.0569</ArticleId><ArticleId IdType="pubmed">33719565</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoen M.S., Singh R.H. Plasma metabolomic profile changes in females with phenylketonuria following a camp intervention. Am. J. Clin. Nutr. 2022;115:811–821. doi: 10.1093/ajcn/nqab400.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/nqab400</ArticleId><ArticleId IdType="pmc">PMC8895208</ArticleId><ArticleId IdType="pubmed">34864852</ArticleId></ArticleIdList></Reference><Reference><Citation>Becsei D., Kiss E., Szatmári I., Arató A., Reusz G., Szabó A.J., Bókay J., Zsidegh P. A retrospective analysis of metabolic control in children with PKU in the COVID-19 era. Mol. Genet. Metab. Rep. 2022;32:100897.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9284369</ArticleId><ArticleId IdType="pubmed">35845719</ArticleId></ArticleIdList></Reference><Reference><Citation>Firman S.J., Ramachandran R., Whelan K. Knowledge, perceptions and behaviours regarding dietary management of adults living with phenylketonuria. J. Hum. Nutr. Diet. 2022;35:1016–1029. doi: 10.1111/jhn.13015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jhn.13015</ArticleId><ArticleId IdType="pmc">PMC9790708</ArticleId><ArticleId IdType="pubmed">35419899</ArticleId></ArticleIdList></Reference><Reference><Citation>Proserpio C., Pagliarini E., Zuvadelli J., Paci S., Re Dionigi A., Banderali G., Cattaneo C., Verduci E. Exploring Drivers of Liking of Low-Phenylalanine Products in Subjects with Phenyilketonuria Using Check-All-That-Apply Method. Nutrients. 2018;10:1179. doi: 10.3390/nu10091179.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu10091179</ArticleId><ArticleId IdType="pmc">PMC6165379</ArticleId><ArticleId IdType="pubmed">30154357</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>